What is Crexendo's operating income?

Crexendo's total operating income in 2025 was $4.69 million, based on the following breakdown: Total Gross Profit: $65.33 million Total Operating Expenses: $60.64 million

Crexendo (CXDO) Financials

$5.88 -0.04 (-0.68%)

Closing price 04:00 PM Eastern

Extended Trading

$5.78 -0.10 (-1.68%)

As of 07:30 PM Eastern

Compare

Annual Income Statements for Crexendo

This table shows Crexendo's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-4.54	-2.79	-0.93	-0.22	1.14	-2.24	-2.45	-35	-0.36	1.68	5.07
Consolidated Net Income / (Loss)	-4.54	-2.79	-0.93	-0.22	1.14	7.94	-2.45	-35	-0.36	1.68	5.07
Net Income / (Loss) Continuing Operations	-4.54	-2.79	-0.93	-0.22	1.14	-2.24	-2.45	-35	-0.36	1.68	5.07
Total Pre-Tax Income	-4.55	-2.78	-0.92	-0.21	1.15	1.90	-2.91	-36	-0.26	1.89	5.37
Total Operating Income	-4.84	-2.76	-0.73	-0.21	1.14	0.99	-2.81	-37	-1.69	1.82	4.69
Total Gross Profit	4.25	5.49	6.92	8.09	10	28	27	36	50	45	65
Total Revenue	7.82	9.12	10	12	14	33	28	38	53	61	68
Operating Revenue	7.82	9.12	10	12	14	33	28	38	53	61	68
Total Cost of Revenue	3.58	3.63	3.27	3.82	4.35	4.95	1.53	1.64	3.33	16	2.84
Operating Cost of Revenue	3.58	3.63	3.27	3.82	4.35	4.95	1.53	1.64	3.33	16	2.84
Total Operating Expenses	9.09	8.26	7.66	8.30	8.95	26	29	73	52	43	61
Selling, General & Admin Expense	5.86	4.90	4.07	4.09	4.24	5.11	11	13	14	14	15
Marketing Expense	2.44	2.53	2.83	3.40	3.86	4.15	8.26	12	15	17	18
Research & Development Expense	0.78	0.83	0.75	0.80	0.85	1.19	1.40	3.96	4.86	5.55	5.72
Other Operating Expenses / (Income)	-	-	-	-	-	15	9.14	12	18	6.79	22
Total Other Income / (Expense), net	0.29	-0.02	-0.19	-0.00	0.01	1.82	-0.10	1.22	1.43	0.07	0.68
Interest Expense	0.03	0.14	0.21	0.01	0.01	-0.93	0.08	0.08	0.12	0.04	0.02
Interest & Investment Income	0.02	0.02	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.19	0.64
Other Income / (Expense), net	0.29	0.11	0.01	0.00	0.02	0.88	-0.02	1.30	1.54	-0.08	0.06
Income Tax Expense	-0.01	0.01	0.01	0.02	0.01	6.04	-0.47	-0.76	0.10	0.21	0.30
Basic Earnings per Share	($0.35)	($0.21)	($0.07)	($0.02)	$0.08	$0.50	($0.12)	($1.54)	($0.01)	$0.06	$0.17
Weighted Average Basic Shares Outstanding	12.96M	13.36M	13.94M	14.33M	14.57M	15.77M	20.28M	22.94M	25.94M	26.76M	29.68M
Diluted Earnings per Share	($0.35)	($0.21)	($0.07)	($0.02)	$0.07	$0.46	($0.12)	($1.54)	($0.01)	$0.06	$0.16
Weighted Average Diluted Shares Outstanding	12.96M	13.36M	13.94M	14.33M	15.56M	17.42M	20.28M	22.94M	25.94M	30.02M	31.64M
Weighted Average Basic & Diluted Shares Outstanding	13.25M	13.65M	14.29M	14.39M	14.90M	17.42M	20.28M	25.70M	26.28M	27.90M	31.15M

This table shows Crexendo's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
Net Income / (Loss) Attributable to Common Shareholders	0.01	0.43	0.59	0.15	0.45	1.17	1.23	1.45	1.22	0.58	1.05
Consolidated Net Income / (Loss)	0.06	0.43	0.59	0.15	0.51	1.17	1.23	1.45	1.22	0.58	1.05
Net Income / (Loss) Continuing Operations	0.01	0.43	0.59	0.15	0.45	1.17	1.23	1.45	1.22	0.58	1.05
Total Pre-Tax Income	0.08	0.46	0.62	0.19	0.62	1.22	1.28	1.49	1.38	0.61	1.08
Total Operating Income	0.04	0.48	0.58	0.14	0.63	1.15	1.10	1.31	1.13	0.44	1.06
Total Gross Profit	17	14	14	15	19	12	12	17	17	19	23
Total Revenue	14	14	15	16	16	16	17	17	18	21	25
Operating Revenue	14	14	15	16	16	16	17	17	18	21	25
Total Cost of Revenue	-2.49	0.73	0.70	1.08	-2.63	4.09	4.24	0.89	0.66	1.67	1.36
Operating Cost of Revenue	-2.49	0.73	0.70	1.08	-2.63	4.09	4.24	0.89	0.66	1.67	1.36
Total Operating Expenses	17	13	13	14	18	11	11	15	16	19	22
Selling, General & Admin Expense	3.32	3.30	3.43	3.70	3.41	3.52	3.59	3.78	3.84	5.06	5.34
Marketing Expense	3.75	4.03	3.96	4.22	4.33	4.29	4.37	4.52	4.59	5.65	7.97
Research & Development Expense	1.26	1.25	1.33	1.47	1.50	1.52	1.44	1.41	1.35	1.57	1.83
Other Operating Expenses / (Income)	8.29	4.50	4.69	5.02	9.00	1.49	1.81	5.59	6.49	6.32	7.10
Total Other Income / (Expense), net	0.04	-0.02	0.04	0.06	-0.01	0.07	0.18	0.19	0.25	0.17	0.02
Interest Expense	0.00	0.01	0.01	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.06
Interest & Investment Income	-	0.01	0.05	0.07	-	0.08	0.13	0.20	0.23	0.16	0.07
Other Income / (Expense), net	0.04	-0.01	-0.01	-0.00	-0.19	-0.01	0.06	-0.01	0.02	0.01	0.01
Income Tax Expense	0.07	0.03	0.03	0.05	0.17	0.04	0.05	0.04	0.17	0.03	0.03
Basic Earnings per Share	-	$0.02	$0.02	$0.01	$0.01	$0.04	$0.04	$0.05	$0.04	$0.02	$0.03
Weighted Average Basic Shares Outstanding	25.94M	26.31M	26.66M	26.85M	26.76M	28.02M	29.43M	30.40M	29.68M	31.53M	32.77M
Diluted Earnings per Share	$0.01	$0.01	$0.02	$0.00	$0.03	$0.04	$0.04	$0.05	$0.03	$0.02	$0.03
Weighted Average Diluted Shares Outstanding	25.94M	30.14M	29.51M	29.86M	30.02M	31.09M	31.32M	31.82M	31.64M	32.68M	34.23M
Weighted Average Basic & Diluted Shares Outstanding	26.28M	26.63M	26.71M	27.10M	27.90M	29.03M	30.17M	30.73M	31.15M	32.42M	33.25M

This table details how cash moves in and out of Crexendo's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-1.41	-0.88	0.66	0.57	2.33	26	-10	-1.99	7.17	7.85	13
Net Cash From Operating Activities	-2.97	-1.13	0.29	0.45	1.64	0.65	-1.01	-0.41	3.50	6.28	9.30
Net Cash From Continuing Operating Activities	-2.79	-0.94	0.41	0.41	1.64	13	3.88	-0.59	5.25	6.28	9.30
Net Income / (Loss) Continuing Operations	-4.54	-2.79	-0.93	-0.22	1.14	7.94	2.45	-35	-0.36	1.68	5.07
Consolidated Net Income / (Loss)	-4.54	-2.79	-0.93	-0.22	1.14	7.94	2.45	-35	-0.36	1.68	5.07
Depreciation Expense	0.27	0.15	0.11	0.09	0.09	0.26	1.63	2.75	3.57	3.33	3.30
Non-Cash Adjustments To Reconcile Net Income	1.47	0.93	0.99	0.46	-0.17	4.91	0.60	32	3.15	1.72	1.06
Changes in Operating Assets and Liabilities, net	-0.40	0.36	0.09	0.13	0.57	-0.35	-0.79	-0.11	-1.11	-0.44	-0.13
Net Cash From Investing Activities	-0.00	0.01	0.25	-0.01	-0.07	14	-9.87	-1.70	3.70	-0.03	-0.02
Net Cash From Continuing Investing Activities	-0.00	0.01	0.25	-0.01	-0.07	-0.92	-9.87	-1.70	3.70	-0.03	-0.02
Purchase of Property, Plant & Equipment	-0.03	-	-	-	-	-	-0.10	-0.29	-0.09	-0.03	-0.02
Net Cash From Financing Activities	1.57	0.24	0.12	0.12	0.77	-0.92	0.65	-0.05	-2.31	1.60	3.88
Net Cash From Continuing Financing Activities	1.57	0.24	0.12	0.12	0.77	14	0.65	0.24	-1.78	1.60	3.88
Repayment of Debt	-0.11	-0.16	-1.16	-0.16	-0.08	-0.09	-0.17	-0.09	-2.34	-0.53	-0.50
Other Financing Activities, net	1.68	0.40	1.16	0.16	0.85	1.99	0.82	0.71	0.41	2.13	4.38
Effect of Exchange Rate Changes	-	-	-	-	-	0.00	0.01	-	-	-0.01	0.02
Cash Interest Paid	-	-	0.01	0.01	0.01	0.07	0.08	0.08	0.12	0.03	0.02
Cash Income Taxes Paid	0.00	0.00	0.01	0.02	0.01	0.01	-0.02	-0.12	-0.12	-0.30	-0.36

This table details how cash moves in and out of Crexendo's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
Net Change in Cash & Equivalents	4.06	0.69	2.57	1.84	12	3.01	2.24	5.12	2.81	-24	11
Net Cash From Operating Activities	2.61	-0.17	2.65	1.62	2.18	1.24	1.30	4.42	2.35	2.04	2.75
Net Cash From Continuing Operating Activities	3.52	-0.17	2.65	1.62	11	1.24	1.30	4.42	2.35	2.04	2.75
Net Income / (Loss) Continuing Operations	-0.79	0.43	0.59	0.15	2.85	1.17	1.23	1.45	1.22	0.58	1.05
Consolidated Net Income / (Loss)	-0.79	0.43	0.59	0.15	2.85	1.17	1.23	1.45	1.22	0.58	1.05
Depreciation Expense	0.88	0.84	0.84	0.83	0.83	0.77	0.86	0.84	0.83	1.17	1.90
Non-Cash Adjustments To Reconcile Net Income	3.21	0.25	0.35	0.18	2.76	0.32	0.53	-0.26	0.47	0.73	0.47
Changes in Operating Assets and Liabilities, net	0.21	-1.69	0.88	0.46	4.10	-1.03	-1.32	2.38	-0.17	-0.44	-0.67
Net Cash From Investing Activities	-	0.00	-	-	-0.03	0.00	-0.02	-	-	-26	0.00
Net Cash From Continuing Investing Activities	-	0.00	-	-	-0.03	0.00	-0.02	-	-	-26	0.00
Acquisitions	-	-	-	-	-	0.00	-	-	-	-26	0.00
Net Cash From Financing Activities	0.02	0.86	-0.08	0.23	0.58	1.76	0.93	0.73	0.46	0.06	8.29
Net Cash From Continuing Financing Activities	0.55	0.86	-0.08	0.23	1.07	1.76	0.93	0.73	0.46	0.06	8.29
Repayment of Debt	-0.19	-0.13	-0.13	-0.13	-0.12	-0.14	-0.12	-0.12	-0.12	-0.11	-0.15
Other Financing Activities, net	0.66	0.99	0.05	0.37	1.19	1.90	1.05	0.85	0.58	0.18	3.43
Effect of Exchange Rate Changes	-	0.00	-0.00	-0.01	-	0.01	0.03	-0.02	-0.00	-0.02	0.00
Cash Income Taxes Paid	-0.03	0.00	-0.19	0.39	-0.10	-0.01	-0.23	0.56	-0.68	0.00	-0.03

This table presents Crexendo's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	5.66	3.53	3.74	4.55	7.78	31	77	56	56	65	78
Total Current Assets	3.30	2.05	2.64	3.33	5.73	20	12	12	17	27	42
Cash & Equivalents	1.50	0.62	1.28	1.85	4.18	18	7.47	5.48	10	18	31
Note & Lease Receivable	-	-	-	0.07	-	-	-	0.64	0.86	1.05	1.42
Accounts Receivable	0.36	0.35	0.37	0.42	0.38	0.54	2.18	3.30	3.48	4.35	4.91
Inventories, net	0.13	0.17	0.13	0.27	0.38	0.50	0.23	0.68	0.38	0.39	0.45
Prepaid Expenses	1.05	0.69	0.25	0.24	0.14	0.19	0.36	0.43	0.51	0.88	0.89
Current Deferred & Refundable Income Taxes	-	-	0.00	0.00	0.00	0.00	0.01	-	0.00	0.08	0.23
Other Current Assets	0.15	0.13	0.51	0.38	0.54	0.87	1.32	1.83	1.38	1.94	2.61
Plant, Property, & Equipment, net	0.03	0.02	0.01	0.12	0.16	2.73	2.99	3.32	0.67	0.39	0.20
Total Noncurrent Assets	2.33	1.47	1.09	1.09	1.90	8.19	63	40	39	38	36
Noncurrent Note & Lease Receivables	0.32	0.04	0.03	0.18	0.57	0.91	0.94	1.26	1.77	2.40	3.22
Goodwill	0.27	0.27	0.27	0.27	0.27	0.27	37	9.45	9.45	9.45	9.45
Intangible Assets	0.47	0.34	0.24	0.17	0.47	0.25	22	27	24	21	18
Other Noncurrent Operating Assets	0.71	0.82	0.54	0.46	0.59	0.71	1.54	2.54	3.76	5.28	5.06
Total Liabilities & Shareholders' Equity	5.66	3.53	3.74	4.55	7.78	31	77	56	56	65	78
Total Liabilities	3.46	3.02	2.11	2.55	3.40	4.94	11	14	12	14	14
Total Current Liabilities	2.30	1.99	1.72	2.01	2.89	2.56	11	10	10	12	12
Short-Term Debt	0.06	0.07	0.07	0.06	0.18	0.07	1.87	0.42	0.46	0.48	0.11
Accounts Payable	0.08	0.12	0.08	0.16	0.09	0.06	0.48	1.21	0.77	1.00	0.65
Accrued Expenses	0.81	1.00	0.96	1.13	1.75	1.63	4.90	4.89	5.95	6.99	8.39
Current Deferred & Payable Income Tax Liabilities	0.48	0.01	-	-	-	0.00	0.02	0.08	0.05	0.04	0.15
Other Current Liabilities	0.10	-	0.61	0.67	0.87	0.81	3.30	3.80	3.03	3.58	3.02
Total Noncurrent Liabilities	1.16	1.03	0.38	0.54	0.51	2.38	0.65	3.78	1.29	1.43	1.54
Long-Term Debt	0.97	0.97	0.01	-	0.00	1.87	0.00	2.69	0.59	0.11	0.00
Capital Lease Obligations	-	-	0.00	-	-	-	-	-	0.47	1.02	0.53
Other Noncurrent Operating Liabilities	0.11	0.02	0.37	0.54	0.51	0.51	0.65	1.10	0.22	0.30	1.01
Total Equity & Noncontrolling Interests	2.20	0.52	1.63	2.00	4.39	26	66	41	45	51	64
Total Preferred & Common Equity	2.20	0.52	1.63	2.00	4.39	26	66	41	45	51	64
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	2.20	0.52	1.63	2.00	4.39	26	66	41	45	51	64
Common Stock	58	59	61	61	62	76	118	129	133	138	145
Retained Earnings	-55	-58	-59	-59	-58	-50	-53	-88	-88	-87	-82
Accumulated Other Comprehensive Income / (Loss)	-	-	-	-	-	0.00	0.01	0.19	0.17	0.16	0.18

This table presents Crexendo's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026
Period end date	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026	6/30/2026
Total Assets	55	57	60	62	67	71	76	91	101
Total Current Assets	16	19	22	24	30	35	39	23	35
Cash & Equivalents	7.74	11	14	15	21	23	29	7.25	18
Note & Lease Receivable	0.81	0.88	0.94	0.98	1.14	1.19	1.34	2.65	2.74
Accounts Receivable	3.87	4.22	3.99	3.75	4.06	5.62	4.75	6.37	6.19
Inventories, net	0.47	0.38	0.55	0.52	0.58	0.62	0.64	1.17	1.38
Prepaid Expenses	0.99	0.90	1.04	1.33	0.99	1.30	1.47	1.33	1.66
Current Deferred & Refundable Income Taxes	-	-	0.08	0.05	0.04	0.23	0.26	0.20	0.21
Other Current Assets	1.73	1.62	1.67	1.78	2.13	2.23	2.29	4.05	4.33
Plant, Property, & Equipment, net	0.76	0.59	0.51	0.44	0.33	0.29	0.24	0.44	0.38
Total Noncurrent Assets	39	38	37	38	37	36	36	68	66
Noncurrent Note & Lease Receivables	1.67	1.87	1.99	2.23	2.55	2.66	3.15	5.52	5.35
Goodwill	9.45	9.45	9.45	9.45	9.45	9.45	9.45	14	14
Intangible Assets	24	23	22	21	20	19	19	40	38
Other Noncurrent Operating Assets	3.49	3.71	3.77	4.99	5.15	4.90	5.15	7.95	8.04
Total Liabilities & Shareholders' Equity	55	57	60	62	67	71	76	91	101
Total Liabilities	12	11	11	13	12	13	15	19	23
Total Current Liabilities	10	9.61	10	11	11	12	14	17	17
Short-Term Debt	0.45	0.46	0.47	0.47	0.48	0.36	0.24	0.00	0.45
Accounts Payable	0.87	0.62	0.91	0.75	0.86	0.52	0.74	2.64	1.38
Accrued Expenses	5.05	5.00	5.92	6.67	6.44	7.47	8.06	9.89	11
Current Deferred & Payable Income Tax Liabilities	0.07	0.08	0.00	0.00	0.04	0.04	0.04	0.15	0.15
Other Current Liabilities	3.65	3.45	3.15	3.26	3.30	3.71	4.53	4.11	4.37
Total Noncurrent Liabilities	1.55	1.09	1.01	1.63	1.11	0.96	1.01	1.78	6.01
Long-Term Debt	0.71	0.48	0.36	0.24	0.00	0.00	0.00	-	4.41
Capital Lease Obligations	-	-	-	-	0.91	0.78	0.66	0.40	0.27
Other Noncurrent Operating Liabilities	0.84	0.61	0.65	1.40	0.21	0.18	0.36	1.38	1.33
Total Equity & Noncontrolling Interests	44	47	48	49	55	58	61	73	78
Total Preferred & Common Equity	44	47	48	49	55	58	61	73	78
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00
Total Common Equity	44	47	48	49	55	58	61	73	78
Common Stock	132	135	135	137	141	142	144	154	158
Retained Earnings	-89	-88	-87	-87	-86	-84	-83	-81	-80
Accumulated Other Comprehensive Income / (Loss)	0.19	0.17	0.17	0.15	0.17	0.21	0.19	0.17	0.17

This table displays calculated financial ratios and metrics derived from Crexendo's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	13,227,289.00	13,413,556.00	14,275,555.00	14,394,113.00	14,714,576.00	17,963,234.00	21,685,214.00	22,756,167.00	26,034,604.00	-	30,731,048.00
DEI Adjusted Shares Outstanding	13,227,289.00	13,413,556.00	14,275,555.00	14,394,113.00	14,714,576.00	17,963,234.00	21,685,214.00	22,756,167.00	26,034,604.00	-	30,731,048.00
DEI Earnings Per Adjusted Shares Outstanding	-0.34	-0.21	-0.07	-0.02	0.08	-0.12	-0.11	-1.56	-0.01	-	0.17
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	3.02%	16.57%	11.71%	16.89%	21.23%	127.03%	-14.29%	33.68%	41.66%	14.36%	12.05%
EBITDA Growth	27.57%	43.67%	74.63%	80.83%	1,221.62%	71.16%	-156.36%	-2,676.85%	110.25%	47.84%	58.71%
EBIT Growth	29.43%	41.59%	72.79%	71.92%	667.00%	62.73%	-250.93%	-1,176.87%	99.58%	1,252.32%	173.16%
NOPAT Growth	26.67%	42.90%	73.43%	71.93%	882.98%	-291.45%	9.00%	-1,230.68%	95.48%	236.96%	173.45%
Net Income Growth	28.78%	38.52%	66.73%	76.00%	610.76%	597.10%	-130.79%	-1,348.38%	98.98%	563.26%	202.39%
EPS Growth	38.60%	40.00%	66.67%	71.43%	450.00%	557.14%	-126.09%	-1,183.33%	99.35%	700.00%	166.67%
Operating Cash Flow Growth	33.14%	62.14%	126.11%	53.74%	262.39%	-60.50%	-255.49%	59.15%	951.34%	79.59%	47.95%
Free Cash Flow Firm Growth	-7.12%	63.64%	98.96%	770.31%	1,000.29%	-1,361.43%	-338.98%	90.57%	143.04%	21.34%	140.01%
Invested Capital Growth	-0.97%	-46.09%	-60.51%	-70.34%	190.72%	3,456.38%	501.64%	-35.21%	-8.45%	-2.67%	-5.02%
Revenue Q/Q Growth	1.56%	2.66%	4.82%	2.44%	4.57%	107.54%	-29.43%	6.97%	5.39%	3.53%	2.74%
EBITDA Q/Q Growth	8.88%	25.72%	43.79%	-37.04%	23.02%	65.32%	-120,000.00%	-2,424.60%	111.52%	6.36%	7.95%
EBIT Q/Q Growth	9.02%	23.30%	41.79%	-18.02%	25.52%	75.54%	-184.69%	-832.74%	99.55%	26.00%	14.17%
NOPAT Q/Q Growth	9.02%	22.84%	41.93%	-11.35%	24.08%	-300.80%	-48.76%	-942.72%	95.35%	42.77%	11.83%
Net Income Q/Q Growth	9.56%	21.02%	37.48%	-21.86%	26.14%	688.48%	-145.98%	-937.29%	98.90%	36.23%	16.31%
EPS Q/Q Growth	14.63%	25.00%	30.00%	-100.00%	40.00%	666.67%	-138.71%	-1,000.00%	99.31%	50.00%	0.00%
Operating Cash Flow Q/Q Growth	12.56%	35.36%	238.68%	-3.21%	30.10%	-28.43%	-304.02%	87.15%	11.40%	-6.47%	1.86%
Free Cash Flow Firm Q/Q Growth	-0.93%	45.43%	93.15%	128.09%	4.32%	-402.78%	10.27%	3.60%	207.35%	-26.84%	22.91%
Invested Capital Q/Q Growth	50.00%	8.38%	395.45%	-59.92%	14.17%	171.64%	-0.48%	-38.18%	-3.56%	0.31%	-1.71%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	54.28%	60.25%	67.94%	67.93%	69.86%	84.91%	94.57%	95.64%	93.74%	94.72%	95.84%
EBITDA Margin	-51.78%	-25.02%	-5.68%	-0.93%	8.62%	6.50%	-4.28%	-88.81%	6.42%	8.31%	11.81%
Operating Margin	-61.86%	-30.30%	-7.21%	-1.73%	7.86%	3.02%	-10.00%	-99.57%	-3.17%	3.00%	6.88%
EBIT Margin	-58.15%	-29.14%	-7.10%	-1.70%	7.97%	5.71%	-10.06%	-96.12%	-0.28%	2.86%	6.97%
Profit (Net Income) Margin	-58.05%	-30.62%	-9.12%	-1.87%	7.89%	24.23%	-8.70%	-94.30%	-0.68%	2.76%	7.44%
Tax Burden Percent	99.74%	100.43%	100.76%	107.21%	99.48%	418.11%	84.02%	97.89%	137.12%	88.78%	94.41%
Interest Burden Percent	100.09%	104.63%	127.52%	102.46%	99.48%	101.39%	102.94%	100.22%	174.83%	108.56%	113.00%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.52%	318.11%	0.00%	0.00%	0.00%	11.22%	5.59%
Return on Invested Capital (ROIC)	-219.46%	-163.63%	-88.97%	-68.02%	595.81%	-41.93%	-5.59%	-52.65%	-3.16%	4.59%	13.04%
ROIC Less NNEP Spread (ROIC-NNEP)	-156.43%	319.69%	-5.09%	-63.10%	595.47%	-143.76%	-1.11%	179.39%	-17.82%	4.13%	10.32%
Return on Net Nonoperating Assets (RNNOA)	84.87%	-41.74%	2.35%	55.73%	-560.14%	94.59%	0.26%	-13.30%	2.32%	-1.09%	-4.24%
Return on Equity (ROE)	-134.59%	-205.37%	-86.62%	-12.29%	35.67%	52.67%	-5.33%	-65.95%	-0.84%	3.49%	8.80%
Cash Return on Invested Capital (CROIC)	-218.48%	-103.73%	-2.22%	40.47%	498.18%	-230.99%	-148.58%	-9.91%	5.66%	7.29%	18.19%
Operating Return on Assets (OROA)	-69.06%	-57.80%	-19.89%	-4.90%	18.67%	9.73%	-5.24%	-54.37%	-0.27%	2.87%	6.67%
Return on Assets (ROA)	-68.94%	-60.74%	-25.56%	-5.38%	18.47%	41.26%	-4.53%	-53.34%	-0.65%	2.77%	7.11%
Return on Common Equity (ROCE)	-134.59%	-205.37%	-86.62%	-12.29%	35.67%	52.67%	-5.33%	-65.95%	-0.84%	3.49%	8.80%
Return on Equity Simple (ROE_SIMPLE)	-206.03%	-542.14%	-56.99%	-11.15%	25.96%	30.82%	-3.71%	-85.42%	-0.81%	3.26%	0.00%
Net Operating Profit after Tax (NOPAT)	-3.39	-1.93	-0.51	-0.14	1.13	-2.16	-1.97	-26	-1.18	1.62	4.43
NOPAT Margin	-43.30%	-21.21%	-5.04%	-1.21%	7.82%	-6.60%	-7.00%	-69.70%	-2.22%	2.66%	6.50%
Net Nonoperating Expense Percent (NNEP)	-63.03%	-483.32%	-83.88%	-4.92%	0.33%	101.83%	-4.48%	-232.04%	14.66%	0.45%	2.72%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	-2.56%	3.05%	6.87%
Cost of Revenue to Revenue	45.72%	39.75%	32.06%	32.07%	30.14%	15.09%	5.43%	4.36%	6.26%	5.28%	4.16%
SG&A Expenses to Revenue	74.93%	53.73%	39.97%	34.36%	29.34%	15.58%	37.68%	34.36%	25.93%	22.73%	21.60%
R&D to Revenue	9.96%	9.06%	7.36%	6.73%	5.91%	3.63%	4.97%	10.53%	9.14%	9.13%	8.39%
Operating Expenses to Revenue	116.13%	90.55%	75.14%	69.66%	62.00%	78.86%	104.57%	195.21%	96.91%	91.72%	88.96%
Earnings before Interest and Taxes (EBIT)	-4.55	-2.66	-0.72	-0.20	1.15	1.87	-2.83	-36	-0.15	1.74	4.75
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-4.05	-2.28	-0.58	-0.11	1.25	2.13	-1.20	-33	3.42	5.05	8.05
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	8.97	38.93	13.09	12.82	14.11	4.78	1.63	1.04	2.83	2.76	3.12
Price to Tangible Book Value (P/TBV)	13.49	0.00	19.07	16.43	16.96	4.88	15.78	8.16	10.88	6.61	5.45
Price to Revenue (P/Rev)	2.53	2.20	2.09	2.15	4.29	3.76	3.82	1.15	2.37	2.33	2.92
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	54.35	0.00	0.00	0.00	0.00	84.52	39.21
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.06%	0.41%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	1.84%	0.00%	0.00%	0.00%	0.00%	1.18%	2.55%
Enterprise Value to Invested Capital (EV/IC)	12.44	24.59	61.27	244.78	204.96	10.72	1.69	1.04	3.28	3.59	5.08
Enterprise Value to Revenue (EV/Rev)	2.44	2.23	1.97	1.99	4.00	3.28	3.62	1.08	2.21	2.06	2.47
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	46.42	50.44	0.00	0.00	34.36	24.77	20.89
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	50.22	57.39	0.00	0.00	0.00	71.93	35.37
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	51.19	0.00	0.00	0.00	0.00	77.29	37.96
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	68.15	52.53	35.29	166.14	0.00	0.00	33.56	19.92	18.08
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	276.74	61.22	0.00	0.00	0.00	55.38	48.64	27.22
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.46	2.00	0.05	0.03	0.04	0.08	0.03	0.07	0.03	0.03	0.01
Long-Term Debt to Equity	0.44	1.88	0.01	0.00	0.00	0.07	0.00	0.06	0.02	0.02	0.01
Financial Leverage	-0.54	-0.13	-0.46	-0.88	-0.94	-0.66	-0.23	-0.07	-0.13	-0.26	-0.41
Leverage Ratio	1.95	3.38	3.39	2.28	1.93	1.28	1.18	1.24	1.30	1.26	1.24
Compound Leverage Factor	1.95	3.54	4.32	2.34	1.92	1.29	1.21	1.24	2.27	1.37	1.40
Debt to Total Capital	31.68%	66.71%	4.62%	2.72%	3.84%	7.02%	2.76%	6.97%	3.30%	3.04%	1.00%
Short-Term Debt to Total Capital	1.77%	4.27%	4.04%	2.72%	3.84%	0.26%	2.76%	0.94%	0.99%	0.90%	0.18%
Long-Term Debt to Total Capital	29.91%	62.44%	0.59%	0.00%	0.00%	6.76%	0.00%	6.03%	2.31%	2.14%	0.82%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	68.32%	33.29%	95.38%	97.28%	96.16%	92.98%	97.24%	93.03%	96.70%	96.96%	99.00%
Debt to EBITDA	-0.25	-0.45	-0.14	-0.50	0.14	0.91	-1.56	-0.09	0.45	0.32	0.08
Net Debt to EBITDA	0.16	-0.14	2.25	17.14	-3.30	-7.38	4.66	0.07	-2.58	-3.28	-3.82
Long-Term Debt to EBITDA	-0.24	-0.42	-0.02	0.00	0.00	0.88	0.00	-0.08	0.31	0.22	0.07
Debt to NOPAT	-0.30	-0.53	-0.15	-0.39	0.16	-0.90	-0.95	-0.12	-1.29	1.00	0.15
Net Debt to NOPAT	0.20	-0.16	2.54	13.20	-3.64	7.28	2.84	0.09	7.46	-10.24	-6.94
Long-Term Debt to NOPAT	-0.28	-0.50	-0.02	0.00	0.00	-0.87	0.00	-0.10	-0.90	0.70	0.12
Altman Z-Score	-11.33	-18.96	-13.62	-9.35	3.28	14.62	5.05	-1.81	5.44	5.72	8.67
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.43	1.03	1.53	1.66	1.99	7.72	1.09	1.19	1.65	2.22	3.40
Quick Ratio	0.81	0.48	0.96	1.16	1.58	7.07	0.91	0.91	1.43	1.95	3.06
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-3.37	-1.23	-0.01	0.09	0.94	-12	-52	-4.93	2.12	2.57	6.18
Operating Cash Flow to CapEx	-11,896.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-996.04%	-142.21%	0.00%	23,274.07%	51,650.00%
Free Cash Flow to Firm to Interest Expense	-120.44	-8.88	-0.06	7.15	78.67	0.00	-622.33	-63.17	18.44	61.27	325.05
Operating Cash Flow to Interest Expense	-106.21	-8.16	1.41	37.67	136.50	0.00	-11.98	-5.27	30.43	149.62	489.32
Operating Cash Flow Less CapEx to Interest Expense	-107.11	-8.16	1.41	37.67	136.50	0.00	-13.18	-8.97	62.60	148.98	488.37
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.19	1.98	2.80	2.87	2.34	1.70	0.52	0.57	0.95	1.00	0.96
Accounts Receivable Turnover	17.25	25.69	28.38	30.11	36.14	71.40	20.69	13.72	15.71	15.54	14.71
Inventory Turnover	34.73	23.85	21.70	19.05	13.35	11.17	4.15	3.60	6.28	8.30	6.69
Fixed Asset Turnover	154.91	357.61	783.62	180.42	103.48	22.69	9.82	11.91	26.70	114.36	231.47
Accounts Payable Turnover	58.16	37.76	33.50	32.64	36.11	69.68	5.73	1.95	3.37	3.63	3.43
Days Sales Outstanding (DSO)	21.16	14.21	12.86	12.12	10.10	5.11	17.64	26.60	23.23	23.48	24.80
Days Inventory Outstanding (DIO)	10.51	15.30	16.82	19.16	27.35	32.69	87.96	101.45	58.13	43.99	54.52
Days Payable Outstanding (DPO)	6.28	9.67	10.90	11.18	10.11	5.24	63.67	187.52	108.21	100.59	106.35
Cash Conversion Cycle (CCC)	25.39	19.85	18.79	20.10	27.34	32.56	41.93	-59.46	-26.84	-33.11	-27.02
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1.54	0.83	0.33	0.10	0.28	10	60	39	36	35	33
Invested Capital Turnover	5.07	7.71	17.64	56.17	76.18	6.36	0.80	0.76	1.42	1.72	2.01
Increase / (Decrease) in Invested Capital	-0.02	-0.71	-0.50	-0.23	0.19	9.75	50	-21	-3.30	-0.95	-1.75
Enterprise Value (EV)	19	20	20	24	58	107	102	41	117	125	168
Market Capitalization	20	20	21	26	62	123	107	43	126	142	199
Book Value per Share	$0.17	$0.04	$0.11	$0.14	$0.30	$1.43	$3.04	$1.82	$1.71	$1.90	$2.08
Tangible Book Value per Share	$0.11	($0.01)	$0.08	$0.11	$0.25	$1.41	$0.31	$0.23	$0.45	$0.79	$1.19
Total Capital	3.23	1.55	1.71	2.06	4.56	28	68	45	46	53	64
Total Debt	1.02	1.03	0.08	0.06	0.18	1.94	1.87	3.11	1.52	1.61	0.64
Total Long-Term Debt	0.97	0.97	0.01	0.00	0.00	1.87	0.00	2.69	1.07	1.14	0.53
Net Debt	-0.67	0.31	-1.30	-1.90	-4.11	-16	-5.60	-2.37	-8.83	-17	-31
Capital Expenditures (CapEx)	0.03	0.00	0.00	0.00	0.00	0.00	0.10	0.29	-3.70	0.03	0.02
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-0.55	-0.60	-0.39	-0.57	-1.26	-0.39	-4.61	-3.10	-3.20	-2.93	-1.70
Debt-free Net Working Capital (DFNWC)	1.06	0.12	0.99	1.38	3.02	17	2.86	2.38	7.15	15	30
Net Working Capital (NWC)	1.00	0.06	0.92	1.32	2.85	17	0.99	1.96	6.69	15	30
Net Nonoperating Expense (NNE)	1.15	0.86	0.42	0.08	-0.01	-10	0.48	9.24	-0.82	-0.06	-0.64
Net Nonoperating Obligations (NNO)	-0.67	0.31	-1.30	-1.90	-4.11	-16	-5.60	-2.37	-8.83	-17	-31
Total Depreciation and Amortization (D&A)	0.50	0.38	0.14	0.09	0.09	0.26	1.63	2.75	3.57	3.31	3.30
Debt-free, Cash-free Net Working Capital to Revenue	-7.08%	-6.54%	-3.85%	-4.80%	-8.73%	-1.19%	-16.40%	-8.24%	-6.02%	-4.81%	-2.49%
Debt-free Net Working Capital to Revenue	13.49%	1.35%	9.72%	11.57%	20.92%	52.75%	10.18%	6.33%	13.43%	25.09%	43.54%
Net Working Capital to Revenue	12.76%	0.63%	9.04%	11.10%	19.71%	52.54%	3.52%	5.22%	12.57%	24.31%	43.38%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.35)	($0.21)	($0.07)	($0.02)	$0.08	$0.00	($0.12)	$0.00	($0.01)	$0.06	$0.17
Adjusted Weighted Average Basic Shares Outstanding	12.96M	13.36M	13.94M	14.33M	14.57M	0.00	20.28M	0.00	25.94M	26.76M	29.68M
Adjusted Diluted Earnings per Share	($0.35)	($0.21)	($0.07)	($0.02)	$0.07	$0.00	($0.12)	$0.00	($0.01)	$0.06	$0.16
Adjusted Weighted Average Diluted Shares Outstanding	12.96M	13.36M	13.94M	14.33M	15.56M	0.00	20.28M	0.00	25.94M	30.02M	31.64M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	13.25M	13.65M	14.29M	14.39M	14.90M	0.00	20.28M	0.00	26.28M	27.90M	31.15M
Normalized Net Operating Profit after Tax (NOPAT)	-3.39	-1.93	-0.51	-0.14	1.13	0.69	-1.97	-3.30	-1.18	1.62	4.43
Normalized NOPAT Margin	-43.30%	-21.21%	-5.04%	-1.21%	7.82%	2.12%	-7.00%	-8.79%	-2.22%	2.66%	6.50%
Pre Tax Income Margin	-58.20%	-30.49%	-9.05%	-1.75%	7.93%	5.79%	-10.36%	-96.33%	-0.50%	3.11%	7.88%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-162.46	-19.25	-3.46	-16.92	95.92	0.00	-33.65	-462.78	-1.31	41.43	250.16
NOPAT to Interest Expense	-120.98	-14.02	-2.46	-12.02	94.09	0.00	-23.42	-335.57	-10.28	38.55	233.05
EBIT Less CapEx to Interest Expense	-163.36	-19.25	-3.46	-16.92	95.92	0.00	-34.86	-466.49	30.86	40.79	249.21
NOPAT Less CapEx to Interest Expense	-121.87	-14.02	-2.46	-12.02	94.09	0.00	-24.62	-339.27	21.89	37.91	232.11
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-1.30%	-35.91%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-1.30%	-35.91%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Crexendo's official financial filings.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
DEI Shares Outstanding	26,034,604.00	26,284,202.00	26,628,022.00	26,714,907.00	-	27,901,072.00	29,030,543.00	30,169,531.00	30,731,048.00	31,152,603.00	32,415,373.00
DEI Adjusted Shares Outstanding	26,034,604.00	26,284,202.00	26,628,022.00	26,714,907.00	-	27,901,072.00	29,030,543.00	30,169,531.00	30,731,048.00	31,152,603.00	32,415,373.00
DEI Earnings Per Adjusted Shares Outstanding	0.00	0.02	0.02	0.01	-	0.04	0.04	0.05	0.04	0.02	0.03
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	23.79%	14.37%	15.90%	12.64%	14.66%	12.40%	12.71%	11.97%	11.21%	28.98%	48.90%
EBITDA Growth	102.98%	315.30%	243.66%	-63.86%	31.56%	45.99%	43.08%	122.27%	42.60%	-15.38%	47.12%
EBIT Growth	100.24%	130.94%	217.42%	-92.56%	448.75%	143.07%	102.44%	882.58%	104.24%	-60.70%	-7.84%
NOPAT Growth	100.03%	141.27%	253.23%	-71.16%	7,133.56%	143.75%	91.45%	1,130.62%	94.44%	-62.20%	-2.93%
Net Income Growth	100.19%	127.43%	207.89%	-91.31%	731.15%	169.82%	109.52%	879.73%	140.24%	-50.64%	-14.69%
EPS Growth	100.70%	116.67%	200.00%	-100.00%	200.00%	300.00%	100.00%	0.00%	0.00%	-50.00%	-25.00%
Operating Cash Flow Growth	15.88%	89.32%	201.02%	3.91%	-16.65%	845.78%	-51.17%	172.49%	7.81%	64.54%	112.43%
Free Cash Flow Firm Growth	211.23%	-79.76%	-89.09%	-90.61%	-57.33%	-42.80%	-82.53%	-6.18%	87.15%	-1,365.52%	-5,985.86%
Invested Capital Growth	-8.45%	-9.16%	-5.76%	-6.42%	-2.67%	-3.45%	1.66%	-3.07%	-5.02%	86.08%	80.49%
Revenue Q/Q Growth	2.09%	0.86%	2.79%	6.41%	3.92%	-1.13%	3.08%	5.71%	3.22%	14.67%	19.01%
EBITDA Q/Q Growth	-64.01%	36.78%	7.64%	-31.80%	22.95%	37.28%	5.49%	5.95%	-7.07%	-18.54%	83.43%
EBIT Q/Q Growth	-95.49%	486.25%	22.17%	-76.96%	118.41%	101.41%	1.75%	11.81%	-10.87%	-61.25%	138.62%
NOPAT Q/Q Growth	-98.23%	7,079.69%	21.95%	-81.43%	344.82%	116.17%	-4.21%	19.38%	-21.34%	-57.97%	145.95%
Net Income Q/Q Growth	-96.42%	611.48%	35.48%	-74.83%	242.57%	130.97%	5.21%	17.69%	-16.00%	-52.55%	81.83%
EPS Q/Q Growth	-83.33%	0.00%	100.00%	-100.00%	0.00%	33.33%	0.00%	25.00%	-40.00%	-33.33%	50.00%
Operating Cash Flow Q/Q Growth	67.44%	-106.36%	1,697.59%	-38.88%	34.30%	-43.13%	4.60%	241.08%	-46.86%	-13.21%	35.05%
Free Cash Flow Firm Q/Q Growth	-87.50%	25.42%	-34.53%	-8.52%	-43.20%	61.88%	-80.01%	391.41%	17.69%	-1,194.67%	7.03%
Invested Capital Q/Q Growth	-3.56%	2.44%	-3.44%	-1.90%	0.31%	1.61%	1.67%	-6.46%	-1.71%	99.06%	-1.38%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	117.54%	94.89%	95.26%	93.08%	116.18%	74.55%	95.85%	94.92%	96.34%	91.92%	94.48%
EBITDA Margin	6.76%	9.16%	9.59%	6.15%	7.75%	11.90%	12.18%	12.21%	10.99%	7.81%	12.03%
Operating Margin	0.27%	3.38%	3.95%	0.86%	3.85%	7.16%	6.66%	7.46%	6.27%	2.12%	4.28%
EBIT Margin	0.56%	3.28%	3.90%	0.84%	2.70%	7.10%	7.01%	7.41%	6.40%	2.16%	4.34%
Profit (Net Income) Margin	0.43%	3.04%	4.00%	0.95%	3.12%	7.29%	7.44%	8.29%	6.74%	2.79%	4.26%
Tax Burden Percent	78.21%	94.14%	95.61%	76.29%	81.91%	96.38%	96.25%	97.12%	88.07%	95.22%	97.68%
Interest Burden Percent	97.50%	98.29%	107.33%	146.97%	141.00%	106.58%	110.34%	115.11%	119.64%	135.49%	100.65%
Effective Tax Rate	83.33%	5.86%	4.39%	23.71%	26.82%	3.62%	3.75%	2.88%	11.93%	4.78%	2.32%
Return on Invested Capital (ROIC)	0.06%	4.55%	5.90%	1.08%	4.86%	12.00%	11.59%	14.05%	11.08%	2.91%	6.70%
ROIC Less NNEP Spread (ROIC-NNEP)	-0.91%	4.93%	5.49%	0.66%	4.48%	11.58%	10.62%	13.19%	10.15%	1.72%	6.59%
Return on Net Nonoperating Assets (RNNOA)	0.12%	-0.60%	-1.00%	-0.15%	-1.18%	-3.40%	-3.50%	-5.05%	-4.17%	-0.36%	-1.71%
Return on Equity (ROE)	0.18%	3.95%	4.90%	0.93%	3.68%	8.60%	8.09%	9.00%	6.91%	2.55%	4.99%
Cash Return on Invested Capital (CROIC)	5.66%	10.47%	9.73%	9.65%	7.29%	9.83%	6.16%	14.69%	18.19%	-52.79%	-50.05%
Operating Return on Assets (OROA)	0.54%	3.25%	3.91%	0.84%	2.72%	7.12%	6.90%	7.12%	6.12%	1.98%	4.07%
Return on Assets (ROA)	0.41%	3.01%	4.01%	0.95%	3.14%	7.31%	7.33%	7.96%	6.45%	2.56%	4.00%
Return on Common Equity (ROCE)	0.18%	3.95%	4.90%	0.93%	3.68%	8.60%	8.09%	9.00%	6.91%	2.55%	4.99%
Return on Equity Simple (ROE_SIMPLE)	0.00%	3.54%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	0.01	0.45	0.55	0.10	0.46	1.11	1.06	1.27	1.00	0.42	1.03
NOPAT Margin	0.04%	3.18%	3.78%	0.66%	2.82%	6.90%	6.41%	7.24%	5.52%	2.02%	4.18%
Net Nonoperating Expense Percent (NNEP)	0.98%	-0.39%	0.41%	0.42%	0.38%	0.42%	0.97%	0.86%	0.93%	1.19%	0.12%
Return On Investment Capital (ROIC_SIMPLE)	0.01%	0.95%	1.13%	0.21%	0.86%	1.96%	1.79%	2.04%	1.55%	0.57%	1.24%
Cost of Revenue to Revenue	-17.54%	5.11%	4.74%	6.92%	-16.18%	25.45%	4.15%	5.08%	3.66%	8.08%	5.52%
SG&A Expenses to Revenue	23.44%	23.07%	23.37%	23.65%	20.97%	21.92%	21.66%	21.60%	21.26%	24.41%	21.65%
R&D to Revenue	8.86%	8.74%	9.04%	9.43%	9.25%	9.49%	8.68%	8.08%	7.45%	7.57%	7.43%
Operating Expenses to Revenue	117.28%	91.51%	91.31%	92.22%	112.33%	67.39%	89.19%	87.47%	90.07%	89.80%	90.20%
Earnings before Interest and Taxes (EBIT)	0.08	0.47	0.57	0.13	0.44	1.14	1.16	1.30	1.16	0.45	1.07
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	0.96	1.31	1.41	0.96	1.26	1.91	2.02	2.14	1.99	1.62	2.97
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.83	2.70	1.74	2.51	2.76	2.46	3.02	3.20	3.12	2.64	3.10
Price to Tangible Book Value (P/TBV)	10.88	8.71	5.02	6.62	6.61	5.24	5.99	5.90	5.45	10.47	9.44
Price to Revenue (P/Rev)	2.37	2.30	1.47	2.11	2.33	2.17	2.73	2.96	2.92	2.64	2.99
Price to Earnings (P/E)	0.00	78.72	30.58	104.78	84.52	56.29	57.62	44.98	39.21	42.92	56.35
Dividend Yield	0.41%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	1.27%	3.27%	0.95%	1.18%	1.78%	1.74%	2.22%	2.55%	2.33%	1.77%
Enterprise Value to Invested Capital (EV/IC)	3.28	3.17	2.00	3.15	3.59	3.28	4.28	5.00	5.08	2.81	3.53
Enterprise Value to Revenue (EV/Rev)	2.21	2.12	1.24	1.86	2.06	1.85	2.39	2.54	2.47	2.55	2.83
Enterprise Value to EBITDA (EV/EBITDA)	34.36	21.79	11.20	23.55	24.77	20.46	24.51	22.59	20.89	23.91	26.31
Enterprise Value to EBIT (EV/EBIT)	0.00	63.43	24.51	87.09	71.93	48.13	51.33	40.46	35.37	45.64	57.68
Enterprise Value to NOPAT (EV/NOPAT)	0.00	345.42	51.12	100.69	77.29	51.01	55.24	42.53	37.96	49.54	61.79
Enterprise Value to Operating Cash Flow (EV/OCF)	33.56	23.80	10.66	16.25	19.92	15.10	24.31	18.45	18.08	18.36	19.82
Enterprise Value to Free Cash Flow (EV/FCFF)	55.38	28.84	19.98	31.49	48.64	32.77	69.98	33.52	27.22	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.03	0.02	0.02	0.01	0.03	0.03	0.02	0.01	0.01	0.01	0.07
Long-Term Debt to Equity	0.02	0.01	0.01	0.00	0.02	0.02	0.01	0.01	0.01	0.01	0.06
Financial Leverage	-0.13	-0.12	-0.18	-0.23	-0.26	-0.29	-0.33	-0.38	-0.41	-0.21	-0.26
Leverage Ratio	1.30	1.27	1.27	1.26	1.26	1.22	1.23	1.25	1.24	1.24	1.26
Compound Leverage Factor	1.27	1.25	1.37	1.86	1.78	1.31	1.36	1.44	1.48	1.68	1.27
Debt to Total Capital	3.30%	1.96%	1.68%	1.41%	3.04%	2.44%	1.91%	1.43%	1.00%	0.55%	6.16%
Short-Term Debt to Total Capital	0.99%	0.97%	0.95%	0.94%	0.90%	0.84%	0.60%	0.38%	0.18%	0.00%	0.55%
Long-Term Debt to Total Capital	2.31%	1.00%	0.73%	0.47%	2.14%	1.60%	1.31%	1.05%	0.82%	0.55%	5.62%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	96.70%	98.04%	98.32%	98.59%	96.96%	97.56%	98.09%	98.57%	99.00%	99.45%	93.84%
Debt to EBITDA	0.45	0.18	0.13	0.15	0.32	0.24	0.18	0.12	0.08	0.05	0.59
Net Debt to EBITDA	-2.58	-1.89	-2.02	-3.18	-3.28	-3.50	-3.55	-3.71	-3.82	-0.88	-1.51
Long-Term Debt to EBITDA	0.31	0.09	0.06	0.05	0.22	0.16	0.12	0.09	0.07	0.05	0.54
Debt to NOPAT	-1.29	2.78	0.59	0.65	1.00	0.61	0.41	0.23	0.15	0.11	1.38
Net Debt to NOPAT	7.46	-30.00	-9.21	-13.59	-10.24	-8.71	-8.01	-6.99	-6.94	-1.83	-3.55
Long-Term Debt to NOPAT	-0.90	1.41	0.26	0.22	0.70	0.40	0.28	0.17	0.12	0.11	1.26
Altman Z-Score	5.45	6.12	3.55	5.05	5.65	6.21	7.77	7.86	8.51	5.86	6.28
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.65	1.98	2.10	2.14	2.22	2.71	2.86	2.89	3.40	1.37	2.06
Quick Ratio	1.43	1.68	1.78	1.81	1.95	2.38	2.50	2.55	3.06	0.97	1.61
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	3.31	4.15	2.72	2.49	1.41	2.37	0.47	2.33	2.74	-30	-28
Operating Cash Flow to CapEx	0.00%	0.00%	0.00%	0.00%	8,062.96%	0.00%	7,194.44%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow to Firm to Interest Expense	827.33	319.29	247.05	355.14	128.37	263.82	79.11	777.47	2,744.95	0.00	-450.59
Operating Cash Flow to Interest Expense	653.00	-12.77	241.09	231.57	197.91	137.56	215.83	1,472.33	2,347.00	0.00	44.37
Operating Cash Flow Less CapEx to Interest Expense	653.00	-12.77	241.09	231.57	195.45	137.56	212.83	1,472.33	2,347.00	0.00	44.37
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.95	0.99	1.00	1.00	1.00	1.00	0.98	0.96	0.96	0.92	0.94
Accounts Receivable Turnover	15.71	13.74	15.12	15.41	15.54	15.13	13.42	15.61	14.71	13.96	13.71
Inventory Turnover	6.28	6.32	4.87	0.04	8.30	41.08	5.25	4.98	6.69	0.48	0.00
Fixed Asset Turnover	26.70	75.08	83.65	98.43	114.36	136.25	160.39	196.29	231.47	189.64	242.26
Accounts Payable Turnover	3.37	4.92	3.74	0.03	3.63	26.56	4.31	3.89	3.43	0.24	0.00
Days Sales Outstanding (DSO)	23.23	26.56	24.14	23.68	23.48	24.12	27.21	23.38	24.80	26.15	26.63
Days Inventory Outstanding (DIO)	58.13	57.77	74.94	8,212.50	43.99	8.88	69.56	73.33	54.52	755.08	0.00
Days Payable Outstanding (DPO)	108.21	74.20	97.53	13,438.64	100.59	13.74	84.69	93.91	106.35	1,515.79	0.00
Cash Conversion Cycle (CCC)	-26.84	10.14	1.55	-5,202.45	-33.11	19.27	12.07	2.80	-27.02	-734.56	26.63
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	36	37	35	35	35	35	36	34	33	66	65
Invested Capital Turnover	1.42	1.43	1.56	1.64	1.72	1.74	1.81	1.94	2.01	1.44	1.60
Increase / (Decrease) in Invested Capital	-3.30	-3.70	-2.16	-2.38	-0.95	-1.27	0.59	-1.07	-1.75	30	29
Enterprise Value (EV)	117	116	71	109	125	116	154	168	168	185	229
Market Capitalization	126	126	84	124	142	136	176	196	199	192	242
Book Value per Share	$1.71	$1.78	$1.81	$1.85	$1.90	$1.98	$2.01	$2.03	$2.08	$2.33	$2.41
Tangible Book Value per Share	$0.45	$0.55	$0.63	$0.70	$0.79	$0.93	$1.01	$1.10	$1.19	$0.59	$0.79
Total Capital	46	48	49	50	53	57	59	62	64	73	83
Total Debt	1.52	0.94	0.82	0.71	1.61	1.38	1.14	0.89	0.64	0.40	5.13
Total Long-Term Debt	1.07	0.48	0.36	0.24	1.14	0.91	0.78	0.66	0.53	0.40	4.68
Net Debt	-8.83	-10	-13	-15	-17	-20	-22	-28	-31	-6.85	-13
Capital Expenditures (CapEx)	0.00	0.00	0.00	0.00	0.03	0.00	0.02	0.00	0.00	0.00	0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-3.20	-1.15	-1.70	-2.26	-2.93	-1.70	-0.57	-2.62	-1.70	-1.01	0.05
Debt-free Net Working Capital (DFNWC)	7.15	9.89	12	13	15	20	23	26	30	6.24	18
Net Working Capital (NWC)	6.69	9.43	11	13	15	19	23	26	30	6.24	18
Net Nonoperating Expense (NNE)	-0.05	0.02	-0.03	-0.05	-0.05	-0.06	-0.17	-0.18	-0.22	-0.16	-0.02
Net Nonoperating Obligations (NNO)	-8.83	-10	-13	-15	-17	-20	-22	-28	-31	-6.85	-13
Total Depreciation and Amortization (D&A)	0.88	0.84	0.84	0.83	0.82	0.77	0.86	0.84	0.83	1.17	1.90
Debt-free, Cash-free Net Working Capital to Revenue	-6.02%	-2.09%	-2.98%	-3.85%	-4.81%	-2.72%	-0.88%	-3.95%	-2.49%	-1.39%	0.06%
Debt-free Net Working Capital to Revenue	13.43%	17.99%	20.89%	22.44%	25.09%	31.16%	35.49%	39.12%	43.54%	8.57%	22.67%
Net Working Capital to Revenue	12.57%	17.15%	20.07%	21.64%	24.31%	30.40%	34.94%	38.76%	43.38%	8.57%	22.11%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.02	$0.02	$0.01	$0.01	$0.04	$0.04	$0.05	$0.04	$0.02	$0.03
Adjusted Weighted Average Basic Shares Outstanding	25.94M	26.31M	26.66M	26.85M	26.76M	28.02M	29.43M	30.40M	29.68M	31.53M	32.77M
Adjusted Diluted Earnings per Share	$0.01	$0.01	$0.02	$0.00	$0.03	$0.04	$0.04	$0.05	$0.03	$0.02	$0.03
Adjusted Weighted Average Diluted Shares Outstanding	25.94M	30.14M	29.51M	29.86M	30.02M	31.09M	31.32M	31.82M	31.64M	32.68M	34.23M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	26.28M	26.63M	26.71M	27.10M	27.90M	29.03M	30.17M	30.73M	31.15M	32.42M	33.25M
Normalized Net Operating Profit after Tax (NOPAT)	0.03	0.45	0.55	0.10	0.46	1.11	1.06	1.27	1.00	0.42	1.03
Normalized NOPAT Margin	0.19%	3.18%	3.78%	0.66%	2.82%	6.90%	6.41%	7.24%	5.52%	2.02%	4.18%
Pre Tax Income Margin	0.55%	3.23%	4.19%	1.24%	3.81%	7.57%	7.73%	8.53%	7.66%	2.93%	4.37%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	20.00	36.08	52.09	18.86	39.91	126.67	193.33	432.33	1,156.00	0.00	17.24
NOPAT to Interest Expense	1.58	34.98	50.41	14.71	41.65	123.15	176.94	422.47	996.95	0.00	16.62
EBIT Less CapEx to Interest Expense	20.00	36.08	52.09	18.86	37.45	126.67	190.33	432.33	1,156.00	0.00	17.24
NOPAT Less CapEx to Interest Expense	1.58	34.98	50.41	14.71	39.19	123.15	173.94	422.47	996.95	0.00	16.62
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-35.91%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-35.91%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials Breakdown Chart

Key Financial Trends

Crexendo’s recent statements show a business that is growing rapidly, but with profitability and financing trends that warrant close monitoring. The company’s Q2 2026 results benefited from strong revenue growth and positive operating cash flow, while sharply higher operating expenses and increased share counts limited the improvement reaching common shareholders.

Revenue growth accelerated. Q2 2026 revenue was $24.6 million, up approximately 49% from $16.6 million in Q2 2025 and 19% from $20.7 million in Q1 2026. This continues the multi-quarter growth trend from $14.3 million in Q1 2024 and $13.9 million in Q3 2023.
Gross margins improved substantially. Gross profit reached $23.3 million in Q2 2026, representing a margin of approximately 94.5%, compared with 74.4% in Q2 2025. The improvement reflects operating costs of revenue falling to about 5.5% of sales from 25.6% a year earlier.
Operating cash flow remained strong. Cash flow from operations increased to $2.8 million in Q2 2026 from $1.3 million in Q2 2025 and $2.0 million in Q1 2026. Operating cash flow has remained positive in each of the provided quarters since Q2 2024, despite fluctuations in working capital.
Liquidity improved sharply during Q2. Cash and equivalents rose to $18.3 million at June 30, 2026, from $7.2 million at March 31, 2026. Current assets of $34.8 million exceeded current liabilities of $16.9 million, producing a current ratio of roughly 2.1.
The company has maintained positive net income. Crexendo reported net income attributable to common shareholders of $1.1 million in Q2 2026, its fourth consecutive profitable quarter in the provided data. Net income also improved from $578,000 in Q1 2026, although it remained below the $1.2 million reported in Q2 2025.
Retained losses have continued to narrow. Accumulated retained earnings improved to a deficit of $80.1 million in Q2 2026 from a deficit of $88.0 million in Q1 2024. Continued profitability could gradually strengthen shareholders’ equity if the trend persists.
Growth has required significant investment and balance-sheet expansion. The Q1 2026 cash flow statement showed $26.2 million of acquisition spending, while total assets increased to $101.0 million by Q2 2026 from $71.4 million in Q2 2025. Investors should evaluate whether acquired assets are generating the expected revenue and cash returns.
Noncash assets make up a substantial portion of the balance sheet. Goodwill and intangible assets totaled approximately $52.5 million in Q2 2026, or more than half of total assets. These balances can support future growth, but impairment charges could reduce equity and earnings if acquired operations underperform.
Operating expenses are rising nearly as quickly as revenue. Total operating expenses increased to $22.2 million in Q2 2026 from $11.2 million in Q2 2025. Marketing expense rose to $8.0 million, and other operating expenses reached $7.1 million, limiting operating income to $1.1 million despite the sharp increase in revenue.
Share dilution and financing dependence are important risks. Basic weighted-average shares increased to 32.8 million in Q2 2026 from 29.4 million in Q2 2025. Q2 cash also benefited from $8.3 million of financing inflows, while debt increased from zero long-term debt and no short-term debt in Q1 2026 to approximately $4.9 million of total debt by Q2, making future per-share growth dependent on continued earnings expansion.

Overall, Crexendo’s financial profile is improving on revenue growth, gross margin and operating cash flow. However, the company’s relatively modest operating profit, rising expenses, acquisition-related assets, share dilution and reliance on financing flows create execution risks. Investors should focus on whether revenue growth begins translating into consistently higher operating margins and earnings per share.

10/09/26 09:53 PM ETAI Generated. May Contain Errors.

Crexendo Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Crexendo's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Crexendo's net income appears to be on a downward trend, with a most recent value of $5.07 million in 2025, compared with -$4.54 million in 2015. The previous period was $1.68 million in 2024. See Crexendo's forecast for analyst expectations on what's next for the company.

Crexendo's total operating income in 2025 was $4.69 million, based on the following breakdown:

Total Gross Profit: $65.33 million
Total Operating Expenses: $60.64 million

Over the last 10 years, Crexendo's total revenue changed from $7.82 million in 2015 to $68.17 million in 2025, a change of 771.4%.

In the past 11 quarters, Crexendo's cash and equivalents has ranged from $7.25 million in Q1 2026 to $28.57 million in Q3 2025, and is currently $18.29 million as of their latest financial filing in Q2 2026.

Crexendo had total debt of $643 thousand at the end of 2025, a 60.2% decrease from 2024, and a 37.1% decrease since 2015.

Over the last 10 years, Crexendo's book value per share changed from 0.17 in 2015 to 2.08 in 2025, a change of 1,146.6%.

Related Companies

Financial statements for NASDAQ:CXDO last updated on 8/5/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Crexendo (CXDO) Financials

Financials Breakdown Chart

Key Financial Trends

Crexendo Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Crexendo (CXDO) Financials

Annual Income Statements for Crexendo

Quarterly Income Statements for Crexendo

Annual Cash Flow Statements for Crexendo

Quarterly Cash Flow Statements for Crexendo

Annual Balance Sheets for Crexendo

Quarterly Balance Sheets for Crexendo

Annual Metrics And Ratios for Crexendo

Quarterly Metrics And Ratios for Crexendo

Financials Breakdown Chart

Key Financial Trends

Crexendo Financials - Frequently Asked Questions

When does Crexendo's fiscal year end?

How has Crexendo's net income changed over the last 10 years?

What is Crexendo's operating income?

How has Crexendo's revenue changed over the last 10 years?

How much cash does Crexendo have?

How much debt does Crexendo have?

How has Crexendo's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools